ArsenalBio Revenue and Competitors
Estimated Revenue & Valuation
- ArsenalBio's estimated annual revenue is currently $71.8M per year.
- ArsenalBio's estimated revenue per employee is $217,000
- ArsenalBio's total funding is $306M.
Employee Data
- ArsenalBio has 331 Employees.
- ArsenalBio grew their employee count by 5% last year.
ArsenalBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Technical Operations Officer | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Chief People Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Scientific Officer | Reveal Email/Phone |
7 | VP, Engineering | Reveal Email/Phone |
8 | VP Quality | Reveal Email/Phone |
9 | VP, Pre-Clinical Pharmacology | Reveal Email/Phone |
10 | VP, Program Management and Alliances | Reveal Email/Phone |
ArsenalBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is ArsenalBio?
ArsenalBio was founded to discover, develop and commercialize curative immune cell therapies
keywords:N/A
$306M
Total Funding
331
Number of Employees
$71.8M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ArsenalBio News
The group's sponsors so far include industry advocate California Life Sciences, Alumis, ArsenalBio, Genentech, Global Blood Therapeutics...
Schroer joins Alumis from ArsenalBio where he served as chief financial officer. Prior to that role, Mr. Schroer served as chief financial...
ArsenalBio, a South San Francisco, Calif.-based programmable cell therapy company, raised $85m in Series A financing. Investors included Westlake Village BioPartners, the Parker Institute for Cancer Immunotherapy (PICI), Kleiner Perkins, the University of California, San Francisco (UCSF) Founda ...
ArsenalBio has exited stealth with $85 million to discover and develop cell therapies. The biotech aims to differentiate itself from the ever-growing pack of cell therapy startups with technology that enables the insertion of large DNA sequences without the use of viral vectors. The design and ...
The story behind ArsenalBio begins with Sean Parker’s Institute for Cancer Immunotherapy. Founded in 2016, the Institute has been instrumental in providing a space for the top researchers into cancer across different fields to collaborate and communicate on the latest breakthroughs in settings ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $127.9M | 379 | 10% | N/A |
#2 | $130.6M | 387 | N/A | N/A |
#3 | $12.8M | 403 | -5% | $59.3M |
#4 | $35M | 421 | 5% | N/A |
#5 | $65.3M | 421 | 7% | N/A |